837421-94-0Relevant articles and documents
BRD4-JAK2 INHIBITORS
-
Page/Page column 137; 140, (2020/03/29)
Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.
Pyrrolopyrimidinyl axl kinase inhibitors
-
Page/Page column 28, (2010/08/18)
Compounds represented by Formula (I): are useful in treating diseases, such as cancer, that are mediated and/or associated (at least in part) with Axl kinase. The compounds can be formulated as pharmaceutically acceptable compositions for administration t
PYRIMIDINYL ARYL UREA DERIVATIVES BEING FGF INHIBITORS
-
Page/Page column 81, (2008/06/13)
The invention relates to heteroaryl aryl ureas of the formula (IA), wherein the radicals and symbols have the meanings as defined herein, the use of such compounds in the treatment of protein kinase dependent diseases; to pharmaceutical preparations comprising said heteroaryl aryl ureas, to processes for the manufacture of such novel compounds and to methods of treatment comprising the use of such heteroaryl aryl ureas.